Viewing Study NCT02400333

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:00 AM
Ignite Modification Date: 2026-03-01 @ 12:34 PM
Study NCT ID: NCT02400333
Status: COMPLETED
Last Update Posted: 2016-09-29
First Post: 2015-03-09
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study to Assess the Bioavailability of Ticagrelor OD Tablet vs. IR Tablet
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bioavailability View
None Healthy Subjects View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ticagrelor orodispersible tablet View
None ticagrelor immediate-release tablet View
None relative bioavailability View
None Phase I View
None healthy subjects View